Epi Biotech Co (XKRX:446440) Interest Expense : ₩ Mil (TTM As of . 20)

View and export this data going back to 2023. Start your Free Trial

What is Epi Biotech Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Epi Biotech Co's interest expense for the six months ended in . 20 was ₩ 0.00 Mil. Epi Biotech Co does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Epi Biotech Co's Operating Income for the six months ended in . 20 was ₩ 0.00 Mil. Epi Biotech Co's Interest Expense for the six months ended in . 20 was ₩ 0.00 Mil. Epi Biotech Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Epi Biotech Co Interest Expense Historical Data

The historical data trend for Epi Biotech Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epi Biotech Co Interest Expense Chart

Epi Biotech Co Annual Data

Trend

Interest Expense

Epi Biotech Co Semi-Annual Data

Interest Expense

Epi Biotech Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Epi Biotech Co (XKRX:446440) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Epi Biotech Co's Interest Expense for the six months ended in . 20 was ₩0.00 Mil. Its Operating Income for the six months ended in . 20 was ₩0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was ₩0.00 Mil.

Epi Biotech Co's Interest Coverage for the quarter that ended in . 20 is calculated as

Epi Biotech Co had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Epi Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Epi Biotech Co Ltd (XKRX:446440) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

32, Songdogwahak-ro, Rooms 1903 and 1904, 15th floor, M-dong, Yeonsu-gu, Incheon, KOR, 21984

Website

http://www.epibiotech.com

Epi Biotech Co Ltd is developing various pipelines for each hair loss treatment modality. It also conducts R&D in skin regeneration treatments to create commercially viable consumer products. The company specializes in hair loss treatment in Korea.

Epi Biotech Co Headlines

No Headlines